| Title |
Author |
Type |
Date |
Words |
| Roche reports interim results for phase III SKYSCRAPER-01 study in PD-L1-high metastatic non-small cell lung cancer. |
|
|
May 12, 2022 |
270 |
| Roche reports interim results for phase III SKYSCRAPER-01 study in PD-L1-high metastatic non-small cell lung cancer. |
|
|
May 12, 2022 |
269 |
| Challenges in Pathology Specimen Processing in the New Era of Precision Medicine. |
Tawfik, Ossama William; Subramanian, Janakiraman; Caughron, Samuel; Mana, Pradip; Ewing, Eric; Aboud |
Report |
May 1, 2022 |
6013 |
| Daiichi Sankyo announces FDA's BTD for patients with HER2 low metastatic breast cancer. |
|
|
Apr 27, 2022 |
274 |
| Daiichi Sankyo announces FDA's BTD for patients with HER2 low metastatic breast cancer. |
|
|
Apr 27, 2022 |
273 |
| Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases. |
Li, Yuanming |
Clinical report |
Apr 27, 2022 |
5584 |
| Bone Cancer Metastases: The chance may be greater than previously thought. |
|
|
Apr 21, 2022 |
210 |
| Preventive Effect of Hippocampal Sparing on Cognitive Dysfunction of Patients Undergoing Whole-Brain Radiotherapy and Imaging Assessment of Hippocampal Volume Changes. |
Shang, Weijie; Yao, Hongmin; Sun, Ying; Mu, Anna; Zhu, Li; Li, Xia |
Report |
Apr 5, 2022 |
4826 |
| Eli Lilly announces updated data from LIBRETTO-001 trial of Retevmo. |
|
|
Apr 1, 2022 |
412 |
| The Benefit of Routine Axillary Sonographic Assessment in cN0 Breast Cancer Patients. |
Khatib, Marian; Sgardelis, Panagiotis; Schneebaum, Schlomo; Schaffer, Ortal; Sutton, Richard |
Report |
Apr 1, 2022 |
2869 |
| First Patient Dosed with AC0176 in Phase 1 Study in Patients with Metastatic Castration-Resistant Prostate Cancer. |
|
|
Mar 30, 2022 |
167 |
| Bristol Myers Squibb, Nektar Post Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metastatic Melanoma. |
|
|
Mar 14, 2022 |
557 |
| Bayer Submits Applications in the US and EU for Additional Indication of Nubeqa. |
|
|
Mar 10, 2022 |
618 |
| Effects of Androgen Deprivation Therapy on Blood Lipids and Fasting Blood Glucose in Patients with Prostate Cancer. |
Yaris, Mehmet |
Report |
Mar 1, 2022 |
3463 |
| Sorafenib in Radioactive Iodine Refractory Differentiated Thyroid Cancer: A Real-life Data with Long-term Experience/Radyoaktif Iyot Direncli Diferansiye Tiroid Kanserinde Sorafenib: Uzun Donem Tecrube ile Gercek Yasam Verisi. |
Yekeduz, Emre; Koksoy, Elif Berna; Senler, Filiz Cay; Akbulut, Hakan; Demirkazik, Ahmet; Urun, Yukse |
|
Mar 1, 2022 |
2115 |
| Using Etomidate in a Two-month-old Infant with Cushing Syndrome due to Adrenocortical Carcinoma. |
Kwon, Ahreum; Choi, Yongha; Jung, Jo Won; Suh, Junghwan; Kim, Ho-Seong |
Clinical report |
Mar 1, 2022 |
2560 |
| City of Hope, Osel Say Live Biotherapeutic Product CBM588 May Enhance Efficacy of Immunotherapy for Patients with Metastatic Kidney Cancer. |
|
|
Feb 28, 2022 |
385 |
| Hyperthermic Intraperitoneal Chemotherapy plus Intravenous Chemotherapy of Paclitaxel with or without Sintilimab in Gastric Cancer: A Comparative Study. |
Zhang, Zao; Ning, Mei-Ying; Han, Dong; Li, Li; Li, Zhuang-Zhuang |
Report |
Feb 22, 2022 |
3988 |
| Olivia Newton-John advocates for medicinal cannabis to be available in Australia; Olivia Newton-John, who was discussing her battle with stage-four metastatic breast cancer, said medicinal cannabis has been helping her remain positive, and wants it to be available as a treatment option for everyone. |
By, Emma Wilson |
|
Feb 17, 2022 |
402 |
| Application of [sup.18]F Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Monitoring Gastric Metastasis and Cancer Thrombi from Renal Cell Carcinoma. |
Xiong, Min; Zhang, Weiguang; Zhou, Chao; Bao, Junjie; Zang, Shengbing; Lin, Xiaoping |
|
Feb 4, 2022 |
8454 |
| Association between Cervical Lymph Node Metastasis and the Incidence of Radiation-Induced Hypothyroidism in Nasopharyngeal Carcinoma. |
Zhou, Ling; Chen, Jia; Tao, Chang-Juan; Zhao, Qing-Feng; Chen, Yu-Ming; Chen, Xiao-Zhong; Chen, Ming |
|
Feb 1, 2022 |
5130 |
| Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma. |
Malone, Eoghan R.; Sim, Hao-Wen; Stundzia, Audrius; Pierre, Sacha; Metser, Ur; OMalley, Matin; Sache |
Report |
Feb 1, 2022 |
5245 |
| Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients. |
El Agy, Fatima; Bardai, Sanae el; Bouguenouch, Laila; Lahmidani, Nada; El Abkari, Mohammed; Benjello |
|
Jan 21, 2022 |
6501 |
| Axillary Reverse Lymphatic Mapping in the Treatment of Axillary Accessory Breast Cancer: A Case Report and Review of Management. |
Friedman-Eldar, Orli; Melnikau, Siarhei; Tjendra, Youley; Avisar, Eli |
Clinical report |
Jan 1, 2022 |
3744 |
| Diagnostic Value of Axillary Ultrasound, MRI, and [.sup.18]F-FDG-PET/CT in Determining Axillary Lymph Node Status in Breast Cancer Patients. |
Aktas, Aysegul; Gurleyik, Meryem Gunay; Aksu, Sibel Aydin; Aker, Fugen; Gungor, Serkan |
Report |
Jan 1, 2022 |
6961 |
| Can Skin Sparing Mastectomy and Immediate Submuscular Implant-Based Reconstruction Be a Better Choice in Treatment of Early-Stage Breast Cancer? |
Kayahan, Munire |
Report |
Jan 1, 2022 |
5485 |
| What Has Changed During the COVID-19 Pandemic? - The Effect on an Academic Breast Department in Portugal. |
Simao, Diana; Sardinha, Mariana; Reis, Ana Filipa; Spencer, Ana Sofia; Luz, Ricardo; Oliveira, Sonia |
Report |
Jan 1, 2022 |
3657 |
| The Impact of the COVID-19 Pandemic on Breast Cancer Patients. |
Ilgun, Ahmet Serkan; Ozmen, Vahit |
Report |
Jan 1, 2022 |
3361 |
| TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer. |
Liu, Cheng-Jiang; Hu, Ting; Shao, Ping; Chu, Wu-Yang; Cao, Yu; Zhang, Feng |
|
Dec 20, 2021 |
7190 |
| Evaluation of Liquid Biopsy in Patients with HER2-Positive Breast Cancer. |
Huai, Jianguo; Cao, Ming; Jiang, Yan; Yang, Xiaomiao; Zhu, Yanyan; Si, Youyi; Xu, Man |
Report |
Dec 3, 2021 |
3702 |
| An Overview of Seminomatous and Non-Seminomatous Germ Cell Testicular Tumors: A Single-center Experience. |
Esen, Selin Akturk; Bal, Oznur; Ergun, Yakup; Acikgoz, Yusuf; Ucar, Gokhan; Dirikoc, Merve; Isak, Oz |
Report |
Dec 1, 2021 |
4920 |
| Bristol Myers Squibb Receives European Commission Approval for Opdivo + Chemotherapy for Patients with HER2 Negative, Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma. |
|
|
Oct 25, 2021 |
499 |
| European Commission Approves US Merck's Keytruda Plus Chemotherapy as Treatment for Certain Patients with Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer. |
|
|
Oct 25, 2021 |
792 |
| First Patient Dosing in a Phase II Study of Tenalisib in Locally Advanced or Metastatic Breast Cancer Patients. |
|
Clinical report |
Oct 18, 2021 |
451 |
| Precirix Doses First Patients in Phase I/II Clinical Study Evaluating CAM-H2 in HER2-Positive Metastatic Cancer. |
|
Clinical report |
Oct 6, 2021 |
482 |
| LATEST COMPANY NEWS. |
|
|
Oct 5, 2021 |
24412 |
| European Medicines Agency Validates Bristol Myers Squibb's Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as First-Line Treatment for Patients with Unresectable or Metastatic Melanoma. |
|
|
Oct 4, 2021 |
464 |
| Pathological Response Rate of Paclitaxel Based Dose Dense and Conventional Neoadjuvant Chemotherapy in Locally Advanced Female Breast Cancer Patients. |
Chellappan, Nonam; Raj, Smitha G. |
|
Oct 4, 2021 |
3310 |
| Development of Oral Tablet Formulation Containing Erlotinib: Randomly Methylated-[beta]-cyclodextrin Inclusion Complex Using Direct Compression Method/Dogrudan Basim Yontemi Kullanilarak Randomize Metillenmis-[beta]-siklodekstrin Inkluzyon Kompleksi Iceren Erlotinib Oral Tablet Formulasyonu Gelistirilmesi. |
Erdogar, Nazli |
Report |
Oct 1, 2021 |
4553 |
| Health Canada Approves Gilead's Trodelvy in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative. |
|
|
Sep 28, 2021 |
255 |
| LATEST COMPANY NEWS. |
|
|
Sep 21, 2021 |
26110 |
| Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma whose Tumors Express PD-L1 with CPS a[per mille][yen ... |
|
|
Sep 20, 2021 |
688 |
| Exelixis announces detailed Phase 1b results from cohort 6 of COSMIC-021 trial. |
|
Financial report |
Sep 19, 2021 |
381 |
| Gilead says data evaluating Trodelvy in patients with TNBC show improvement. |
|
|
Sep 16, 2021 |
243 |
| Novocure, Roche team to evaluate TTFields for metastatic pancreatic cancer. |
|
|
Sep 14, 2021 |
260 |
| US Merck's Keytruda Approved in China in Combination with Chemotherapy for First-Line Treatment of Patients with Locally Advanced Unresectable or Metastatic Esophageal or Gastroesophageal Junction Carcinoma. |
|
|
Sep 7, 2021 |
169 |
| Coherus, Junshi announce completion of rolling BLA submission for toripalimab. |
|
|
Sep 1, 2021 |
259 |
| The Use of PSM A Targeted Therapy and Hormone Therapy in Renally Impaired Patient. |
Lenzo, Nat; Sohi, Jaideep S. |
|
Sep 1, 2021 |
1007 |
| TARGETING THE TUMOR METABOLISM BY OXAMATE POTENTIATES THE IMPACT OF CHEMOTHERAPEUTICS IN COLORECTAL CANCER CELLS. |
Calibasi-Kocal, Gizem; Cakici, Cagri; Toksoz, Feriha; Inanc-Surer, Seniz; Sever, Tolga; Basbinar, Ya |
|
Sep 1, 2021 |
3316 |
| The Effects of NT and Adjuvant Treatments on Anastomotic Leakage in Rectal Cancer/Neoadjuvan ve Adjuvan Tedavinin Rektum Kanseri Uzerindeki Etkileri. |
Asratova, Nigara; Cakcak, Ibrahim Ethem; Coskun, Irfan |
Report |
Sep 1, 2021 |
5873 |
| WHAT'S NEW IN METASTATIC COLON CANCER TREATMENT?/METASTATIK KOLON KANSERI TEDAVISINDEKI YENILIKLER. |
Karabulut, Senem; Karabulut, Mehmet; Tastekin, Didem |
Report |
Sep 1, 2021 |
3323 |
| First Patient Treated in Phase 2a Trial of Infigratinib in Patients with Gastric Cancer and Other Advanced Solid Tumors. |
|
|
Aug 27, 2021 |
722 |
| Enhertu Significantly Improved Progression-Free Survival in DESTINY-Breast03 Head-to-Head Trial Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer. |
|
|
Aug 10, 2021 |
639 |
| The role of adjuvant radiation therapy for locoregionally recurrent papillary thyroid carcinoma. |
Hwang, Hyun; Lee, Nam Kwon |
Report |
Aug 1, 2021 |
3625 |
| Long-Term Efficacy of Ultrasound-Guided Percutaneous Laser Ablation for Low-Risk Papillary Thyroid Microcarcinoma: A 5-Year Follow-Up Study. |
Peng, Kai; Zhou, Ping; Liu, Wengang |
Report |
Jul 23, 2021 |
5263 |
| Palliative local treatment of bone metastases by [.sup.125]l seed brachytherapy under DynaCT guidance: single-center experience. |
Yao, Yuan; Li, Zhaonan; Jiao, Dechao; Zhou, Xueliang; Li, Jing; Han, Xinwei |
Report |
Jul 1, 2021 |
3514 |
| Use of full-dose contrast-enhanced CT for extrahepatic staging using Gallium-68-DOTATATE PET/CT in patients with neuroendocrine tumors. |
Apitzsch, Jonas; Verburg, Frederik Anton; Mottaghy, Felix; Heinzel, Alexander |
Report |
Jul 1, 2021 |
5160 |
| First Patient Treated in Phase 1 Study of DCC-3116 in Patients with Advanced or Metastatic Tumors with a Mutant RAS or RAF Gene. |
|
|
Jun 30, 2021 |
461 |
| Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis. |
Sheykhhasan, Mohsen; Kalhor, Naser; Sheikholeslami, Azar; Dolati, Masoumeh; Amini, Elaheh; Fazaeli, |
Report |
Jun 30, 2021 |
8802 |
| Moleculin Biotech enrolls, doses first patient in phase 1b/2 trial of annamycin. |
|
|
Jun 21, 2021 |
237 |
| Replimune Group plans to initiate Phase 2 development of RP2/RP3. |
|
|
Jun 3, 2021 |
207 |
| PDS Biotechnology expands VERSATILE-002 study of PDS0101, Keytruda. |
|
|
Jun 3, 2021 |
247 |
| Data Mining Analysis of Gene Prognostic Markers of Metastatic Skin Cancer Based on the Elastic Network Method. |
Liu, Gang; Li, Chen; Wei, Wenhao; Li, Wentao; Zhen, Haiyan |
|
Jun 2, 2021 |
4980 |
| Magnetic Resonance Imaging Signal Changes Mimicking Bone Metastasis in Patients Receiving Bisphosphonate Therapy/Bifosfonat Tedavisi Almis Hastalarda Kemik Metastazini Taklit Eden Manyetik Rezonans Goruntuleme Sinyal Degisiklikleri. |
Tamsel, Ipek; Argin, Mehmet; Akgun, Aysegul |
Clinical report |
Jun 1, 2021 |
600 |
| Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo plus Yervoy for Treatment of Mismatch Repair Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer After Prior Chemotherapy. |
|
|
May 25, 2021 |
426 |
| Regeneron, Sanofi receive CHMP recommendation for two Libtayo treatments. |
|
|
May 24, 2021 |
262 |
| BeiGene Touts Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy. |
|
|
May 21, 2021 |
726 |
| Diagnostic performance of [.sup.18]F-DCFPyL positron emission tomography/computed tomography for biochemically recurrent prostate cancer and change-of-management analysis. |
Chausse, Guillaume; Ben-Ezra, Noah; Stoopler, Michelle; Levett, Jeremy Y.; Niazi, Tamim; Anidjar, Ma |
Report |
May 4, 2021 |
4239 |
| Urological outcomes in nonagenarians with prostate cancer. |
White, Josh; Ory, Jesse; Morris, Heather; Rendon, Ricardo A.; Mason, Ross; Cox, Ashley |
Report |
May 4, 2021 |
2891 |
| Application of Carbon Nanoparticles in Neck Dissection of Clinically Node-Negative Papillary Thyroid Carcinoma. |
Chen, Zhongyan; Zhong, Zhiming; Chen, Guoqing; Feng, Yun |
Report |
Apr 22, 2021 |
4205 |
| Biocept changing the way physicians examine blood work for their cancer patients and doing coronavirus testing. |
|
|
Apr 15, 2021 |
846 |
| Phase 2 Trial of Enhertu Initiated in Patients with HER2 Overexpressing Advanced Colorectal Cancer. |
|
|
Apr 6, 2021 |
745 |
| Merck Receives Positive EU CHMP Opinion for Updated Label of Keytruda to Include Results of Phase 3 KEYNOTE-361 Trial in Certain Adult Patients with Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Mar 31, 2021 |
350 |
| European Commission Approves Pemazyre as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement. |
|
|
Mar 30, 2021 |
791 |
| Roche's Tecentriq receives positive CHMP opinion as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer. |
|
|
Mar 29, 2021 |
252 |
| Roche's Tecentriq receives positive CHMP opinion as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer. |
|
|
Mar 29, 2021 |
251 |
| Biocept changing the way physicians examine blood work for their cancer patients and doing coronavirus testing. |
|
|
Mar 19, 2021 |
838 |
| miR-22-3p/PGC1ß Suppresses Breast Cancer Cell Tumorigenesis via PPAR? . |
Wang, Xuehui; Yao, Zhilu; Fang, Lin |
|
Mar 13, 2021 |
5217 |
| The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcinoma following radical surgery. |
Tam, Andrew W.; Liaw, Christine; Li, Eric; Katims, Andrew B.; Say, Rollin K.; Gul, Zeynep; Winoker, |
Report |
Mar 4, 2021 |
4814 |
| Nutritional medical therapy in cachexia patient with oesophageal adenocarcinoma metastases on dexamethasone therapy: A case report. |
Stefani, Shiela; Andayani, Diyah Eka |
Clinical report |
Feb 28, 2021 |
1661 |
| TOP NEWS: AstraZeneca Withdraws Imfinzi's US Bladder Cancer Indication. |
|
|
Feb 22, 2021 |
376 |
| Seagen's Tukysa Receives European Commission Approval the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer. |
|
|
Feb 16, 2021 |
197 |
| ANGLE liquid biopsy proves its worth assessing lung cancer patients. |
|
|
Feb 9, 2021 |
342 |
| ANGLE liquid biopsy proves its worth assessing lung cancer patients. |
|
|
Feb 9, 2021 |
342 |
| Incyte Receives Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement. |
|
|
Feb 2, 2021 |
660 |
| UPDATE--2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) castration-resistant prostate cancer (CRPC) guideline: What has changed since 2019? |
Saad, Fred |
|
Feb 1, 2021 |
1178 |
| Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists. |
Hotte, Sebastien J.; Finelli, Antonio; Chi, Kim N.; Canil, Christina; Fleshner, Neil; Kapoor, Anil; |
Report |
Feb 1, 2021 |
4868 |
| Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies/Cocukluk Cagi Malignitelerinde [.sup.18]Flor-florodeoksiglukoz PET/BT Goruntuleme. |
Bicakci, Nilufer; Elli, Murat |
Report |
Feb 1, 2021 |
6117 |
| Ga PSMA Uptake at Roux-en-Y Eso-jejunostomy Junction Mimicking the Recurrence of Gastric Carcinoma in PET/CT/[.sup.68]Ga PSMA PET/BT Goruntulemede Roux-en-Y Oeso-jejunostomi Anastomoz Hattinda Gastrik Karsinomun Nuksunu Taklit Eden PSMA Tutulumu. |
Arslan, Esra; Aksoy, Tamer; Cin, Merve; Cakir, Coskun; Trabulus, Fadime Didem Can; Cermik, Tevfik Fi |
Clinical report |
Feb 1, 2021 |
749 |
| US FDA Accepts for Priority Review Incyte BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal. |
|
|
Jan 22, 2021 |
652 |
| Enhertu Approved in the EU for the Treatment of HER2 Positive Metastatic Breast Cancer. |
|
|
Jan 21, 2021 |
890 |
| Enhertu Approved in the U.S. for the Treatment of Patients with Previously Treated HER2 Positive Advanced Gastric Cancer. |
|
|
Jan 15, 2021 |
698 |
| Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience. |
Patil, Roshankumar; Pandit, Prakash; Palwe, Vijay; Kate, Shruti; Gandhe, Sucheta; Patil, Rahul; Rame |
Report |
Jan 1, 2021 |
3885 |
| Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer? |
Luz, Paulo |
Letter to the editor |
Jan 1, 2021 |
812 |
| Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America. |
Manneh, Ray; Brugés, Ricardo; Correa, Jose Jaime; Rojas, Julián; Rojas, Daniel; Villareal, Nicolás |
Disease/Disorder overview |
Jan 1, 2021 |
4759 |
| Role of miRNA-495 and NRXN-1 and CNTN-1 mRNA Expression and Its Prognostic Importance in Breast Cancer Patients. |
Alkhathami, Ali G.; Verma, Amit Kumar; Alfaifi, Mohammed; Kumar, Lalit; Alshahrani, Mohammad Yahya; |
|
Jan 1, 2021 |
6168 |
| The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients. |
Zamzam, Yomna; Abdelmonem Zamzam, Yosra; Aboalsoud, Marwa; Harras, Heba |
|
Jan 1, 2021 |
5945 |
| Rhabdomyosarcoma in Adults: A Retrospective Analysis of Case Records Diagnosed between 1979 and 2018 in Western Denmark. |
Mäkinen, Vivi-Nelli; Safwat, Akmal; Aggerholm-Pedersen, Ninna |
|
Jan 1, 2021 |
5755 |
| Effect of Prophylactic Radiotherapy on Patients with Stage II-III Esophageal Cancer after Esophageal Cancer Radical Operation and Influencing Factors in Its Recurrence. |
Guo, Dan; Zheng, Kang |
|
Jan 1, 2021 |
4105 |
| Long-Term Efficacy of Ultrasound-Guided Percutaneous Laser Ablation for Low-Risk Papillary Thyroid Microcarcinoma: A 5-Year Follow-Up Study. |
Peng, Kai; Zhou, Ping; Liu, Wengang |
Report |
Jan 1, 2021 |
5263 |
| Double Endoprosthesis in the Management of Refractory Metastatic Primary Bone Tumors in Children and Young Adults. |
Raciborska, Anna; Malesza, Iwona; Bilska, Katarzyna; Kozinski, Tomasz; Pachuta, Bartosz |
|
Jan 1, 2021 |
4735 |
| Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma. |
Formozo, A. A.; Gomes, J. R.; Schmerling, R. A.; Buzaid, A. C. |
|
Jan 1, 2021 |
1858 |
| Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis. |
Sheykhhasan, Mohsen; Kalhor, Naser; Sheikholeslami, Azar; Dolati, Masoumeh; Amini, Elaheh; Fazaeli, |
Report |
Jan 1, 2021 |
8801 |
| Heart Dissemination: A Clinical Case of Melanoma. |
André, Diogo; André, Teresa; Gouveia, Fabiana; Nascimento, Rafael; Chaves, António; Brazão, Ma |
|
Jan 1, 2021 |
1534 |
| The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma. |
Zhang, Jian-Yu; Shi, Ke-Zhi; Liao, Xiang-Yu; Li, Shi-Jun; Bao, Dan; Qian, Ying; Li, Dao-Jun |
Report |
Jan 1, 2021 |
4803 |
| Data Mining Analysis of Gene Prognostic Markers of Metastatic Skin Cancer Based on the Elastic Network Method. |
Liu, Gang; Li, Chen; Wei, Wenhao; Li, Wentao; Zhen, Haiyan |
Report |
Jan 1, 2021 |
4981 |
| Biliothoracic Fistula after Microwave Ablation of Liver Metastasis:Literature Review. |
Tassi, Valentina; Mosillo, Claudia; Mutignani, Massimiliano; Cirocchi, Roberto; Ragusa, Mark; Bracar |
|
Jan 1, 2021 |
2501 |
| Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer. |
Guo, Jiani; Yi, Xuesong; Ji, Zhuqing; Yao, Mengchu; Yang, Yu; Song, Wei; Huang, Mingde |
|
Jan 1, 2021 |
8651 |
| Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy. |
Nasse, Nicola J.; Chernyak, Victoria; Shankar, Viswanathan; Garg, Madhur; Bodner, William; Kalnicki, |
Report |
Jan 1, 2021 |
5136 |
| LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma. |
Zhang, Xiaoting; Kang, Huaning; Xiao, Jing; Shi, Benyan; Li, Xiaofeng; Chen, Guihong |
Report |
Dec 22, 2020 |
3197 |
| A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer. |
Samar, Aseem; Tiwari, Srikant; Subramanian, Sundaram; Joshi, Nisarg; Sejpal, Jaykumar; Khan, Mujtaba |
Clinical report |
Dec 16, 2020 |
4229 |
| Reconstruction of Bony Defects after Tumor Resection with 3D-Printed Anatomically Conforming Pelvic Prostheses through a Novel Treatment Strategy. |
Peng, Wei; Zheng, Runlong; Wang, Hongmei; Huang, Xunwu |
Report |
Dec 1, 2020 |
7702 |
| Is Complete Mesocolic Excision Technique Superior to Conventional Hemicolectomy Technique for Patients with Right-Sided Colon Cancer? Preliminary Findings from a Single-Center Retrospective Analysis/Sag Kolon Kanserinde Tam Mezokolik Eksizyon Teknigi Standart Hemikolektomi Tekniginden Ustun Mudur? Tek Merkez Erken Donem Retrospektif Analiz Sonuclari. |
Tumay, Latif Volkan; Guner, Osman Serhat; Bati, Imam Bakir; Zorluoglu, Abdullah |
Report |
Dec 1, 2020 |
6203 |
| Agri Palyasyonunda Radyonuklit Tedavi/Radionuclide Treatment in Pain Palliation. |
Elboga, Umut; Selcuk, Nalan Alan |
Report |
Dec 1, 2020 |
5803 |
| Erector Spinae Plane Block for Computed Tomographic Scan Guidance Percutaneous Radiofrequency Ablation of Pulmonary Metastasis: Three Cases. |
Ozkan, Derya; Arik, Emine; Hekimoglu, Azad; Mumcu, Ozge Yamankilic; Ergun, Onur |
Letter to the editor |
Dec 1, 2020 |
941 |
| Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. |
Gotto, Geoffrey; Drachenberg, Darrel E.; Chin, Joseph; Casey, Richard; Fradet, Vincent; Sabbagh, Rob |
Report |
Dec 1, 2020 |
3969 |
| Breast metastasis from medullary carcinoma of thyroid: A case report with literature view. |
|
Clinical report |
Nov 30, 2020 |
1256 |
| Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria. |
Rendl, G.; Sipos, B.; Becherer, A.; Sorko, S.; Trummer, C.; Raderer, M.; Hitzl, W. |
|
Nov 29, 2020 |
5874 |
| A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature. |
Wang, Yihua; Wang, Yu; Chen, Rui; Tang, Zhenrong; Liu, Shengchun |
Report |
Nov 10, 2020 |
6891 |
| Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients. |
Qu, Yuqing; Li, Haoming; Wang, Xianling; Chen, Yulong; Guo, Qinghua; Pei, Yu; Du, Jin |
|
Nov 6, 2020 |
4573 |
| Breast Cancer Metastasis to the Endometrium. |
Farkas, Amy; Rigney, Debbie; Shenoy, Veena; Nutter, Kathryn |
|
Nov 1, 2020 |
653 |
| ELECTIVE CENTRAL COMPARTMENT LYMPH NODE DISSECTION DOES NOT INCREASE THE RISK OF POSTOPERATIVE HYPOPARATHYROIDISM IN PATIENTS TREATED FOR DIFFERENTIATED THYROID CANCER/ELEKTIVNA DISEKCIJA REGIJE VI NE POVECAVA RIZIK POSTOPERATIVNOG HIPOPARATIREOIDIZMA KOD BOLESNIKA LIJECENIH ZBOG DOBRO DIFERENCIRANOG KARCINOMA STITNJACE. |
Stubljar, Boris; Grgic, Marija PastorCiC; Mayer, Ljiljana; Perse, Pavao; Tomicevic, Tomislav |
Report |
Nov 1, 2020 |
3561 |
| Case--Highly aggressive urothelial carcinoma of the bladder presenting with solitary metastasis to the phalanx. |
Assem, Hisham; Broeke, Nolan; Coleman, Lance; Gotto, Geoffrey; Bismar, Tarek A. |
Clinical report |
Nov 1, 2020 |
2367 |
| Clinical Characteristics of Colorectal Cancer Patients in terms of Selected Platelet Indices. |
Copija, Angelika; Nowakowska-Zajdel, Ewa; Janion, Karolina; Walkiewicz, Katarzyna |
|
Oct 9, 2020 |
4993 |
| Mickey Mouse Sign on Bone Scan in the Monostotic Form of Paget's Disease Mimicking Osseous Metastasis/Metastazi Taklit Eden Monostotik Tip Paget Hastaligi'nda Mickey Mouse Isareti. |
Kesim, Selin; Turoglu, Halil Turgut; Ozguven, Salih; Ones, Tunc; Erdil, Tanju Yusuf |
Report |
Oct 1, 2020 |
366 |
| Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China. |
Wang, Qianyu; Guo, Guifang; Ruan, Zhaohui; Cao, Huijiao; Guo, Ying; Bai, Long; Jiang, Chang |
|
Sep 30, 2020 |
6417 |
| Tukysa, trastuzumab Combination Approved in Australia for Patients with Advanced Unresectable or Metastatic HER2-Positive Breast Cancer. |
|
|
Aug 13, 2020 |
489 |
| The efficacy of positron emission tomography-CT in simultaneously detected nodules in patients with lung cancer. |
Dogan, Coskun; Kiral, Nesrin; Parmaksiz, Elif Torun; Zengin, Omer; Caglayan, Benan; Fidan, Ali; Come |
|
Apr 3, 2020 |
5223 |
| Evaluation of radiotherapy combined with targeted therapy and concurrent radiotherapy, chemotherapy in the treatment of Non-Small Cell Lung Cancer with brain metastasis. |
Yanfeng Sun, Xiaohui Guo, Lingling Zhang, Wenqian Zhang and Yuqin Zuo |
|
Apr 2, 2020 |
3308 |
| Medlab Clinical shares surge on "primary evidence" of NanaBis[TM] cancer trial success. |
|
|
Mar 10, 2020 |
718 |
| ANGLE device plays key role in assessing spread of lung cancer to the brain. |
|
|
Mar 4, 2020 |
434 |
| CytoDyn sees +remarkable outcomes' in metastatic triple-negative breast cancer trial for leronlimab. |
|
|
Mar 3, 2020 |
879 |
| Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Feb 19, 2020 |
407 |
| Opdivo Plus Yervoy Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Feb 19, 2020 |
647 |
| CytoDyn sees positive data for leronlimab in Phase 1b/2 mTNBC and expanded access studies for MBC. |
|
|
Feb 15, 2020 |
913 |
| US Merck's Keytruda in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival as First-Line Treatment for Metastatic Triple-Negative Breast Cancer. |
|
|
Feb 14, 2020 |
1258 |
| Nubeqa Plus Androgen Deprivation Therapy Achieved the Secondary Endpoint of Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Feb 4, 2020 |
361 |
| Dose fall-off during the treatment of thoracic spine metastasis with CyberKnife stereotactic body radiation therapy (SBRT). |
Ju, Zhongjian; Wang, Jingyuan; Zhang, Huaiwen; Du, Lei; Xu, Wei; Wang, Xiaoshen; Ge, Ruigang; Li, Ji |
Report |
Feb 1, 2020 |
5192 |
| European Commission Approves Janssen for Expanded Use of Erleada for Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer. |
|
|
Jan 30, 2020 |
217 |
| Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint. |
|
|
Jan 27, 2020 |
1636 |
| A Canadian consensus forum on the management of patients with advanced prostate cancer. |
Saad, Fred; Canil, Christina; Finelli, Antonio; Hotte, Sebastien J.; Malone, Shawn; Shayegan, Bobby; |
|
Jan 25, 2020 |
7582 |
| CytoDyn's impressive run continues for leronlimab in metastatic triple-negative breast cancer and metastatic breast cancer. |
|
|
Jan 23, 2020 |
689 |
| Lynparza regulatory submission granted Priority Review in the US for HRR-mutated metastatic castration-resistant prostate cancer. |
|
|
Jan 20, 2020 |
237 |
| CytoDyn files for breakthrough therapy status for leronlimab in metastatic triple-negative breast cancer. |
|
|
Jan 14, 2020 |
758 |
| Intractable small-bowel obstruction due to urothelial cell carcinoma metastasis to the distal ileum: A rare cause of malignant bowel obstruction. |
Tseng, Yu-Chen; Lin, Hsuan-Hwai; Huang, Shing-Hwa; Wen, Liang-Wei |
|
Jan 1, 2020 |
1521 |
| The Choice of Local Treatment Modalities for Patients with Brain Metastases from Digestive Cancers. |
Dong, Jun; Wu, Liyan; Wang, Fang; Huang, Jinsheng; Hu, Pili; Zhang, Bei; Xia, Liang-ping |
Clinical report |
Dec 31, 2019 |
8239 |
| The Antioxidant Alpha-Lipoic Acid Inhibits Proliferation and Invasion of Human Gastric Cancer Cells via Suppression of STAT3-Mediated MUC4 Gene Expression. |
Yang, Yu; Fang, Erhu; Luo, Jiajun; Wu, Hongxue; Jiang, Yue; Liu, Ying; Tong, Shilun; Wang, Zhihua; Z |
|
Dec 31, 2019 |
5835 |
| Skeletal Muscle Metastasis to Vastus Lateralis from a Urothelial Carcinoma: A Case Report and Review of Its Diagnosis and Management. |
Mainwaring, A.M.; Wells, H.; Banks, T.; Ellul, T.; Bose, P. |
|
Dec 31, 2019 |
2832 |
| Increased Tissue Penetration of Doxorubicin in Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) after High-Intensity Ultrasound (HIUS). |
Khosrawipour, Veria; Reinhard, Soren; Martino, Alice; Khosrawipour, Tanja; Arafkas, Mohamed; Mikolaj |
|
Dec 31, 2019 |
3813 |
| Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression. |
Yosra, Macherki; Sameh, Souissi; Randa, Ghedira; Yassmine, Remadi; Sallouha, Gabbouj; Nadia, Bouzid; |
|
Dec 31, 2019 |
7564 |
| Lynparza approved in the US as a 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer. |
|
|
Dec 30, 2019 |
2269 |
| Seattle submits NDA with FDA for tucatinib to treat metastatic HER2-positive breast cancer. |
|
|
Dec 24, 2019 |
265 |
| Seattle submits NDA with FDA for tucatinib to treat metastatic HER2-positive breast cancer. |
|
|
Dec 24, 2019 |
264 |
| CytoDyn's leronlimab sees strong positive clinical responses in two patients with metastatic breast cancer and mTNBC. |
|
|
Dec 24, 2019 |
634 |
| Continuing Full Induction Regimen Not Beneficial in Metastatic CRC; Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival. |
|
|
Dec 20, 2019 |
268 |
| Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer; ODAC voted that Lynparza demonstrated a clinically meaningful and favourable risk-benefit profile for patients based ... |
|
|
Dec 18, 2019 |
2484 |
| CytoDyn sees positive results as first triple-negative breast cancer patient treated with leronlimab. |
|
|
Dec 4, 2019 |
441 |
| NantKwest Releases Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients with Locally Advanced or Metastatic Solid Cancers. |
|
|
Dec 4, 2019 |
509 |
| Nivolumab may be beneficial for metastatic cervical cancer. |
Sullivan, Michele |
|
Dec 1, 2019 |
321 |
| CytoDyn wins IRB approval to give leronlimab to triple-negative breast cancer patients on compassionate grounds. |
|
|
Nov 14, 2019 |
481 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Nov 13, 2019 |
2170 |
| Celyad Highlights Safety and Clinical Activity of CYAD-101, a First-In-Class, Non-Gene Edited Allogeneic CAR-T Therapy for mCRC, from SITC 34th Annual Meeting. |
|
|
Nov 11, 2019 |
1087 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Nov 6, 2019 |
2171 |
| Establishment of primary human epithelial ovarian cancer cells and their application to cytotoxicity assessment. |
Wang, Chun-Kai; Lin, Cheng-Kuo; Huang, Li-Chun; Chou, Ssu-Jen; Lin, Chi-Kang; Chang, Cheng-Chang |
Disease/Disorder overview |
Nov 1, 2019 |
2362 |
| WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?/U KOJIH BOLESNIKA PRIMIJENITI RADIOTERAPIJU U METASTATSKOM HORMONALNO OSJETLJIVOM KARCINOMU PROSTATE? |
Bisof, Vesna |
Clinical report |
Nov 1, 2019 |
4001 |
| WHICH PATIENTS WILL BENEFIT MOST FROM DOCETAXEL ADDITION TO ANDROGEN DEPRIVATION THERAPY (ADT) IN METASTATIC CASTRATE-SENSITIVE PROSTATE CANCER (MCSPC)?/U KOJIH BOLESNIKA PRIMIJENITI HORMONSKU TER APIJU + DOCETAKSEL. |
Gamulin, Marija; Bebek, Marko; Gnjidic, Milena |
Disease/Disorder overview |
Nov 1, 2019 |
1082 |
| CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER/IZAZOVI MANIPULIRANJA IMUNOLOSKIM SUSTAVOM U SVRHU LIJECENJA RAKA PROSTATE. |
Samija, Ivan; Frobe, Ana |
|
Nov 1, 2019 |
3409 |
| Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma. |
Zhao, Lingdi; Yang, Yonghao; Ma, Baozhen; Li, Wei; Li, Tiepeng; Han, Lu; Zhang, Yong; Shang, Yi-Man; |
Clinical report |
Oct 31, 2019 |
6049 |
| Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer. |
Giuffrida, Dario; Giuffrida, Raffaella; Puliafito, Ivana; Vella, Veronica; Memeo, Lorenzo; Puglisi, |
|
Oct 31, 2019 |
4826 |
| Neoadjuvant chemotherapy in combination with surgery in the treatment of local advanced breast cancer. |
Haixia Zhao, Jinying Zhang, Yanxia Lu and Jihai Jin |
|
Oct 31, 2019 |
3589 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Oct 30, 2019 |
1763 |
| Bristol-Myers Squibb UK (NYSE: BMY) - European Commission Approves Opdivo (nivolumab) Four-Week Dosing Schedule for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease Who Have Undergone Complete Resection -- 24/10/2019. |
|
|
Oct 29, 2019 |
408 |
| Prognostic Factors and Survival Outcome of Whole Brain Radiotherapy in Metastatic Brain Cancer- A Single Regional Cancer Centre Experience in North India. |
Thakur, Purnima; Sharma, Aman; Gupta, Manish; Dhiman, Anupama; Sharma, Jyoti |
|
Oct 28, 2019 |
3686 |
| Oncolytics Biotech's therapy shows 11 month improvement in overall survival in metastatic breast cancer patients. |
|
|
Oct 25, 2019 |
135 |
| EduCare Announces New Recurrent and Metastatic Breast Cancer Treatment Handbook. |
|
|
Oct 24, 2019 |
469 |
| JAMA Oncology Publishes Analysis of Patients with Prior Gastrectomy Treated with Lonsurf. |
|
|
Oct 23, 2019 |
984 |
| Daiichi Sankyo Company, Limited - [Fam-] Trastuzumab Deruxtecan (DS-8201) Granted FDA Priority Review for Treatment of Patients with HER2 Positive Metastatic Breast Cancer -- 17/10/2019. |
|
|
Oct 22, 2019 |
340 |
| AstraZeneca (NYSE: AZN) - Trastuzumab deruxtecan granted FDA Priority Review for treatment of patients with HER2-positive metastatic breast cancer -- 17/10/2019. |
|
|
Oct 21, 2019 |
310 |
| Eli Lilly & Company (NYSE: LLY) - Lilly Announces Phase 3 Study in Patients with Metastatic Pancreatic Cancer Did Not Meet Primary Endpoint of Overall Survival -- 16/10/2019. |
|
|
Oct 21, 2019 |
492 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Oct 17, 2019 |
1915 |
| Immutep reports efficacy data for TACTI-mel Phase 1 clinical study. |
|
|
Oct 15, 2019 |
273 |
| Sanofi - New England Journal of Medicine publishes data showing improved survival with Jevtana[R] (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer - 30/9/2019. |
|
|
Oct 10, 2019 |
323 |
| Johnson & Johnson (NYSE: JNJ) - Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Niraparib for the Treatment of Metastatic Castration-Resistant Prostate Cancer -- 3/10/2019. |
|
|
Oct 7, 2019 |
583 |
| Sanofi - New England Journal of Medicine publishes data showing improved survival with Jevtana[R] (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer -- 30/9/2019. |
|
|
Oct 2, 2019 |
323 |
| AstraZeneca (NYSE: AZN) - Lynparza more than doubled the time without radiographic disease progression in patients with BRCA1/2- or ATM-mutated metastatic castration-resistant prostate cancer -- 30/9/2019. |
|
|
Oct 1, 2019 |
1134 |
| AstraZeneca Data Shows Tagrisso as the Only 1st-line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer to Deliver a Median Overall Survival of More Than Three Years. |
|
|
Oct 1, 2019 |
580 |
| What is the Diagnostic Performance of 18F-FDG-PET/MRI in the Detection of Bone Metastasis in Patients with Breast Cancer? |
Celebi, Filiz |
|
Oct 1, 2019 |
3064 |
| Roche's Satralizumab Achieves Positive Phase III Results in NMOSD: Merck KGaA's tepotinib granted Breakthrough Designation in non-small cell lung cancer. |
|
|
Oct 1, 2019 |
1712 |
| Single-Agent Thalidomide for Treatment of Malignant Paraganglioma of the Organ of Zuckerkandl. |
Shindorf, Mackenzie L.; Chaudhuri, Prabir K. |
|
Sep 30, 2019 |
1777 |
| Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver. |
Velayati, Sara; Erinjeri, Joseph P.; Brody, Lynn A.; Ziv, Etay; Boas, Franz E.; Brown, Karen T.; Cov |
|
Sep 30, 2019 |
4002 |
| Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy". |
Cho, Edwin; Ballman, Karla; Chen, James; Dickson, Mark A.; George, Rashmi Chugh Suzanne; Okuno, Scot |
Correction notice |
Sep 30, 2019 |
359 |
| Response of Leptomeningeal Metastases in EGFR-Mutated Non-Small-Cell Lung Cancer to Afatinib in the Absence of Radiotherapy. |
Llinas-Quintero, Nestor; Gonzalez-Hoyos, David; Yepes, Andres; Herrera, Diego A.; Pelaez-Arroyave, S |
|
Sep 30, 2019 |
3099 |
| Prolonged Treatment Response to Pembrolizumab in a Patient with Pretreated Metastatic Colon Cancer and Lynch Syndrome. |
Keating, Matthew; Giscombe, Lisa; Tannous, Toufic; Hartshorn, Kevan |
|
Sep 30, 2019 |
2638 |
| Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. |
Fei, Fei; Zhang, Mingqing; Li, Bo; Zhao, Lizhong; Wang, Hui; Liu, Lina; Li, Yuwei; Ding, Po; Gu, Yan |
|
Sep 30, 2019 |
8468 |
| Tagrisso is the only 1st-line treatment for EGFR-mutated non-small cell lung cancer to deliver a median overall survival of more than three years. |
|
|
Sep 30, 2019 |
2054 |
| Lynparza more than doubled the time without radiographic disease progression in patients with BRCA1/2- or ATM-mutated metastatic castration-resistant prostate cancer. |
|
|
Sep 30, 2019 |
900 |
| Daiichi Sankyo Company, Limited - Daiichi Sankyo Advances [Fam-] Trastuzumab Deruxtecan (DS-8201) in Japan with Regulatory Submission in HER2 Positive Metastatic Breast Cancer -- 9/9/2019. |
|
|
Sep 10, 2019 |
1348 |
| Puma's Breast Cancer Drug Accorded Orphan Drug Designation For Brain Metastases. |
|
|
Sep 4, 2019 |
347 |
| Cancer care investigation; DGRI patient's complaint upheld MARC MCLEAN. |
|
|
Sep 3, 2019 |
390 |
| FDA grants orphan status to Puma's Nerlynx for brain metastases. |
|
|
Sep 3, 2019 |
193 |
| Registry study results support baseline imaging for all patients. |
Bosworth, Ted |
Clinical report |
Sep 1, 2019 |
531 |
| Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital. |
Zahid, Khawaja F.; Kumar, Shiyam; Bimani, Khalid Al-; Ahmed, Tanweer; Ajmi, Adil Al-; Burney, Ikram |
|
Sep 1, 2019 |
5101 |
| Ocular Iridociliary Adenoma in a Congo African Grey Parrot (Psittacus erithacus). |
Thielen, Lauren E.; Sledge, Dodd G.; Hess, Laurie |
|
Sep 1, 2019 |
3590 |
| Nektar Therapeutics and Bristol-Myers Squibb were granted Breakthrough Therapy Designation by the FDA for investigational agent bempegaldesleukin (NKTR-214) in combination with Bristol-Myers Squibb's Opdivo (nivolumab) for the treatment of patients with Previously untreated unresectable or metastatic melanoma. |
|
Clinical report |
Sep 1, 2019 |
194 |
| Comparison of Treatment Outcomes in Patients with Rectal Cancer. |
Erdis, Eda; Yucel, Birsen |
|
Sep 1, 2019 |
5261 |
| Results of Vincristine, Cyclophosphamide and Topotecan Protocol in Refractory/Relapsed Pediatric Solid Tumors: A Single-center Experience. |
Demirsoy, Ugur; Corapcioglu, Funda; Karadogan, Meriban |
|
Sep 1, 2019 |
3027 |
| The Effect of Transarterial Y-90 Microsphere Treatment on Biochemical Parameters in Liver Tumors/Karaciger Tumorlerinde Transarteriyel Y-90 Mikrokure Tedavisinin Biyokimyasal Parametreler Uzerine Etkisi. |
Yilmaz, Burcak; Gundogan, Cihan |
|
Sep 1, 2019 |
3454 |
| A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity. |
Post, J.; Houdek, M.; Folpe, A.L.; Kakar, S.K.; Wilke, B.K. |
|
Aug 31, 2019 |
4515 |
| Emerging Risk Profile of Lung Cancer Therapy: Diffuse Alveolar Hemorrhage from Osimertinib. |
Forte, Michael J.; Sangani, Rahul G. |
|
Aug 31, 2019 |
2686 |
| Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous Carcinoma. |
Sadagopan, Narayanan; Devoe, Craig |
|
Aug 31, 2019 |
1728 |
| Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events. |
Swami, Umang; Monga, Varun; Bossler, Aaron D.; Zakharia, Yousef; Milhem, Mohammed |
|
Aug 31, 2019 |
3740 |
| Association of ESR1 Mutations and Visceral Metastasis in Patients with Estrogen Receptor-Positive Advanced Breast Cancer from Brazil. |
Reinert, Tomas; Coelho, Guilherme Portela; Mandelli, Jovana; Zimermann, Edineia; Zaffaroni, Facundo; |
Clinical report |
Aug 31, 2019 |
3658 |
| Physical Activity, Overall Survival Not Linked in Metastatic CRC; Nine or more MET hours per week tied to lower risk for grade ≥3 treatment-related adverse events. |
|
|
Aug 28, 2019 |
278 |
| Pfizer Inc. (NYSE: PFE) - U.S. FDA Grants Xtandi[R] (Enzalutamide) Application Priority Review For The Treatment Of Men With Metastatic Hormone-Sensitive Prostate Cancer -- 21/8/2019. |
|
|
Aug 27, 2019 |
559 |
| Astellas Pharma Inc. - U.S. FDA Grants XTANDI[R] (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer - 21/8/2019. |
|
|
Aug 27, 2019 |
546 |
| US FDA Grants XTANDI Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer. |
|
|
Aug 23, 2019 |
396 |
| Astellas Pharma Inc. - U.S. FDA Grants XTANDI[R] (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer -- 21/8/2019. |
|
|
Aug 22, 2019 |
547 |
| Astellas Pharma and Pfizer submit sNDA for XTANDI for treating metastatic hormone-sensitive prostate cancer. |
|
|
Aug 22, 2019 |
328 |
| Astellas Pharma and Pfizer submit sNDA for XTANDI for treating metastatic hormone-sensitive prostate cancer. |
|
|
Aug 22, 2019 |
324 |
| Hepatitis C and three cancers now covered on basic plan in Dubai. |
|
|
Aug 16, 2019 |
600 |
| Vascular Endothelial Growth Factor (VEGF) Expression in Oral Cancer and its Correlation with Clinico-Pathological Parameters-A Prospective Study. |
Singhal, Ashish; Hadi, Rahat; Mahajan, Charu; Husain, Nuzhat |
Clinical report |
Aug 5, 2019 |
3208 |
| Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital. |
Zhang, Yang; Huang, Zhigang; Gross, Neil; Fang, Jugao; Chen, Xiaohong; Chen, Xuejun; Hou, Lizhen; Li |
|
Jul 31, 2019 |
2399 |
| Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US. |
Kawai, Alison Tse; Martinez, David; Saltus, Catherine W.; Vassilev, Zdravko P.; Soriano-Gabarro, Mon |
|
Jul 31, 2019 |
4312 |
| Cutaneous Basal Cell Carcinoma with Bone Metastases: An Orthopaedic Case Report. |
Fram, Brianna R.; Strony, John; Jagannathan, Geetha; Brown, Scot A. |
|
Jul 31, 2019 |
3203 |
| Lonsurf Receives Positive Opinion from CHMP in the EU for Patients with Previously Treated Metastatic Gastric Cancer. |
|
|
Jul 30, 2019 |
831 |
| Delcath Systems announces results of single center study of PHP Therapy. |
|
|
Jul 22, 2019 |
375 |
| Exelixis Updates Phase 1b COSMIC-021 Trial of Cabozantinib in Combination with Atezolizumab in Patients with Advanced Solid Tumors. |
|
|
Jul 16, 2019 |
1007 |
| Hepatoid Carcinoma of the Ovary: Clinical, Histopathologic, and Immunophenotypic Features. |
Acosta, Andres M.; Pins, Michael R. |
|
Jul 1, 2019 |
6042 |
| Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study. |
Comert, Gunsu Kimyon; Turkmen, Osman; Boyraz, Gokhan; Yalcin, Ibrahim; Altin, Duygu; Karalok, Alper; |
|
Jul 1, 2019 |
4940 |
| Overview of Patients with Multiple Primary Tumors During Eighty-four Months Follow-up: A Single Center Experience/Seksen-dort Aylik Izlemde Coklu Primer Tumor Tanili Hastalarimiza Bakis: Tek Merkez Deneyimi. |
Mermut, Ozlem; Gursu, Riza Umar |
Disease/Disorder overview |
Jul 1, 2019 |
3157 |
| Surgical Treatment of a Patient with a Solitary Thyroid Metastasis from Primary Sigmoid Adenocarcinoma: A Case Report and Literature Review. |
Yamahara, Kohei; Moriki, Toshiaki; Katsura, Yuki; Lee, Kana; Ikegami, Satoshi |
|
Jun 30, 2019 |
2860 |
| High Expression and Clinical Significance of Elafin in Colorectal Cancer. |
Liu, Yun; Tian, Yu; Wu, Ting; Dai, Yun; Wang, Weihong; Teng, Guigen |
|
Jun 30, 2019 |
4325 |
| The Three P's: Parotid, PD-L1, and Pembrolizumab. |
Wiggins, Amanda; Arter, Zhaohui; Kerns, Tamie |
|
Jun 30, 2019 |
1955 |
| Management algorithms for metastatic prostate cancer. |
Malone, Shawn; Shayegan, Bobby; Basappa, Naveen S.; Chi, Kim; Conter, Henry J.; Hamilton, Robert J.; |
|
Jun 27, 2019 |
8597 |
| Xoma's gevokizumab used to dose first patient in cancer study by Novartis. |
|
|
Jun 13, 2019 |
103 |
| LabCorp and Qiagen Launch New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer. |
|
|
Jun 11, 2019 |
470 |
| Lynparza First-Line Maintenance Therapy Nearly Doubled the Time Without Disease Progression or Death in Phase 3 POLO Trial for Patients with Germline BRCA-Mutated Metastatic Pancreatic Cancer. |
|
|
Jun 4, 2019 |
760 |
| Sufferers of cancer given new hope. |
|
|
Jun 3, 2019 |
147 |
| US Merck's Keytruda Demonstrates Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial. |
|
|
Jun 3, 2019 |
383 |
| Erleada Significantly Improved Overall Survival and Radiographic Progression-Free Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer. |
|
|
Jun 3, 2019 |
239 |
| Seattle Genetics, Astellas announce data from cohort of EV-201 trial. |
|
|
Jun 3, 2019 |
516 |
| Evaluation of Mandibular Morphometry in the Bisphosphonate Users/Evaluacion de la Morfometria Mandibular en los Usuarios de Bifosfonatos. |
Busra, Tanrikol; Guldane, Magat |
|
Jun 1, 2019 |
7347 |
| Downregulation of lncRNA CCDC26 contributes to imatinib resistance in human gastrointestinal stromal tumors through IGF-1R upregulation. |
Yan, Jingyi; Chen, Didi; Chen, Xiaolei; Sun, Xuecheng; Dong, Qiantong; Hu, Changyuan; Zhou, Feng; Ch |
|
Jun 1, 2019 |
3976 |
| Honokiol and Magnolol Inhibit Growth, Metastasis and Induce Apoptosis in Human Cholangiocarcinoma. |
Songjang, Worawat; Jiraviriyakul, Arunya |
|
Jun 1, 2019 |
6338 |
| Capecitabine Induced Hand-Foot Syndrome: A Systematic Review of Case Reports. |
Aras, Elif; Tecen-Yucel, Kamer; Bayraktar-Ekincioglu, Aygin; Gullu, Ibrahim |
Report |
Jun 1, 2019 |
10872 |
| Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma. |
Fazel, Mahdieh; Jedlowski, Patrick M. |
|
May 31, 2019 |
1815 |
| Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience. |
Jumayli, Mohammed Al-; Batool, Amna; Middiniti, Akshay; Saeed, Anwaar; Sun, Weijing; Rajabi, Raed Al |
|
May 31, 2019 |
3864 |
| Treatment of Spinal Metastases with Epidural Cord Compression through Corpectomy and Reconstruction via the Traditional Open Approach versus the Mini-Open Approach: A Multicenter Retrospective Study. |
Zhou, Xi; Cui, Haomin; He, Yu; Qiu, Guixing; Zhou, Dongsheng; Liu, Yong |
|
May 31, 2019 |
4784 |
| A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm. |
Zhu, Wang-Yu; Fang, Ke-Xin; He, Jian-Ying; Cui, Ri; Zhang, Yong-Kui; Le, Han-Bo |
Clinical report |
May 31, 2019 |
6090 |
| Anti-Invasion and Antimetastatic Effects of Porcine Recombinant NK-lysin on SMMC-7721 Human Hepatocellular Carcinoma Cells. |
Fan, Kuohai; Du, Wenjuan; Wang, Zhirui; Khan, Ajab; Li, Hongquan; Jiang, Junbing |
|
May 31, 2019 |
3803 |
| Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center. |
Cardi, Maurizio; Sibio, Simone; Di Marzo, Francesco; Lefoche, Francesco; d'Agostino, Claudia; Fonsi, |
|
May 31, 2019 |
5467 |
| US Merck Provides Update on Phase 3 KEYNOTE-119 Study of Keytruda Monotherapy in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer. |
|
|
May 22, 2019 |
437 |
| Assesment of symptom burden and related factors of patients with lung cancer in a palliative care unit. |
Kizilgoz, Derya; Yesildagli, Havva; Kabalak, Pinar Akin; Cengiz, Tuba Inal; Yilmaz, Ulkii |
Report |
May 1, 2019 |
2298 |
| Breast Carcinoma Metastasis to the Medial Rectus Muscle: Case Report. |
Kiziloglu, Ozge Yabas,; Turkoz, Fatma Paksoy; Gedar, Ozgun Melike Totuk; Mestanoglu, Mert; Yapicier, |
|
May 1, 2019 |
1823 |
| Isolated Unilateral Infiltrative Optic Neuropathy in a Patient with Breast Cancer. |
Aghdam, Kaveh Abri; Zand, Amin; Sanjari, Mostafa Soltan |
|
May 1, 2019 |
1783 |
| Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research. |
Koumpa, Foteini Stefania; Xylas, Diamantis; Konopka, Maciej; Galea, Dieter; Veselkov, Kirill; Antoni |
|
Apr 30, 2019 |
18730 |
| Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience. |
Karivedu, Vidhya; Eldessouki, Ihab; Taftaf, Ahmad; Zhu, Zheng; Makramalla, Abouelmagd; Karim, Nagla |
Clinical report |
Apr 30, 2019 |
5527 |
| Sequential Interventional Management of Osseous Neoplasms via Embolization, Cryoablation, and Osteoplasty. |
Sundararajan, Sri Hari; Calamita, Steven; Girgis, Peter; Ngo, Gregory; Ranganathan, Srirajkumar; Gig |
|
Apr 30, 2019 |
3470 |
| Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. |
Fiorentini, Chiara; Grisanti, Salvatore; Cosentini, Deborah; Abate, Andrea; Rossini, Elisa; Berruti, |
|
Apr 30, 2019 |
5933 |
| Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol. |
Wang, Dongying; Zhao, Chunhua; Fu, Li; Liu, Yang; Zhang, Weiyang; Xu, Tianmin |
|
Apr 30, 2019 |
3702 |
| Prognostic Value of [sup.18]F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel. |
Quaquarini, E.; D'Ambrosio, D.; Sottotetti, F.; Gallivanone, F.; Hodolic, M.; Baiardi, P.; Palumbo, |
|
Apr 30, 2019 |
4785 |
| Clinicopathologic and Prognostic Significance of Body Mass Index (BMI) among Breast Cancer Patients in Western China: A Retrospective Multicenter Cohort Based on Western China Clinical Cooperation Group (WCCCG). |
Wang, Kang; Wu, Yu-Tuan; Zhang, Xiang; Chen, Li; Zhu, Wen-Ming; Zhang, Ai-Jie; Zheng, Ke; Yin, Xue-D |
|
Apr 30, 2019 |
9244 |
| Seattle Genetics (NASDAQ: SGEN)-Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer--28/3/2019. |
|
|
Apr 3, 2019 |
580 |
| Seattle Genetics and Astellas Tout Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Apr 1, 2019 |
723 |
| A RETROSPECTIVE STUDY OF TH.E IMPACT OF RADIATION FRACTIONATION ON PAINFUL BONE METASTASIS. |
Suresh, Kumar K.; Thomas, Flowerlit; Nair, Ajith; Mathew, Mintu; Snigdha, P.P. |
Report |
Apr 1, 2019 |
4957 |
| Tonsillar and Parotid Gland Metastases of Breast Cancer: Two Cases and A Literature Review. |
Cengiz, Abdurrahman Bugra; Comert, Ela; Tuncel, Omit; Dilek, Gulay; Benzer, Emine |
|
Apr 1, 2019 |
1926 |
| Cytogenetic Studies of Chromosome Abnormalities in Thyroid Cancer Patients Before and After Iodine-131 Treatment. |
Oden, Seda; Atasoy, Sezen; Demir, Mustafa; Deviren, Ayhan |
|
Apr 1, 2019 |
3809 |
| European Commission Approves US Merck's Keytruda (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer. |
|
|
Mar 15, 2019 |
497 |
| Celgene Provides Update on Abraxane Combination Therapy in the Treatment of Metastatic Triple-Negative Breast Cancer and Pancreatic Cancer. |
|
|
Mar 14, 2019 |
668 |
| Odonate Therapeutics Initiates CONTESSA 2, a Phase 2 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a Taxane. |
|
|
Mar 6, 2019 |
657 |
| DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION ([less than or equal to]18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131). |
Prpic, Marin; Franceschi, Maja; Jukic, Tomislav; Kust, Davor; Dabelic, Nina; Varjacic, Tea; Lucijani |
|
Mar 1, 2019 |
4846 |
| Secondary Prevention of Bone Disease In Men on Androgen Deprivation Therapy For Prostate Cancer: Quality Improvement Through Implementation of Evidence-Based Bone Health Guidelines. |
LaRoche, Mary Jane; Makic, Mary Beth Flynn; Shaw, Kathy |
|
Mar 1, 2019 |
9017 |
| Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study/Ucuncu Basamakta Regorafenib ile Tedavi Edilen Metastatik Kolorektal Kanserli Hastalarin Sonuclari-Cok Merkezli Calisma. |
Sahin, Suleyman; Hacioglu, Muhammet Bekir |
|
Mar 1, 2019 |
3427 |
| Opdivo Plus Yervoy Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer. |
|
|
Feb 20, 2019 |
544 |
| US Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Programme with Three New Phase 3 Trials. |
|
|
Feb 15, 2019 |
1895 |
| European Medicines Agency Adopts Positive Opinion for US Merck's Keytruda in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC). |
|
|
Feb 4, 2019 |
430 |
| Pfizer receives positive CHMP opinion for Vizimpro. |
|
|
Feb 1, 2019 |
214 |
| A Pathologist's Guide to Creating an Informative Report and Improving Patient Care. |
Prats, Mariana Moreno; Sasatomi, Eizaburo; Stevenson, Heather L. |
Report |
Feb 1, 2019 |
4100 |
| Perspectives in veterinary medicine on the use of cannabinoids as complementary palliative therapy for pain in cancer patients/Perspectivas sobre o uso de canabinoides como terapeutica paliativa complementar da dor em pacientes oncologicos na medicina veterinaria. |
Repetti, Claudia Sampaio Fonseca; Girio, Raul Jose Silva; Friolani, Milena; Barbalho, Sandra Maria |
|
Feb 1, 2019 |
4431 |
| The Role of [.sup.18]F-FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 Levels/CA-125 Duzeylerinde Artis Olan Over Kanserli Hastalarda Rekurrens Saptamada [.sup.18]F-FDG PET/BT'nin Rolu. |
Cengiz, Arzu; Koc, Zehra Pinar; Kara, Pelin Ozcan; Yurekli, Yakup |
|
Feb 1, 2019 |
3938 |
| False-positive I-131 Uptakes at Pulmonary Wedge-resection Site and Soft Tissue Lateral to the Femoral Heads in a Patient with Papillary Thyroid Carcinoma/Papiller Tiroid Kanserli Bir Hastada Akcigerde Kama-Rezeksiyon Alaninda ve Femur Baslarinin Lateralinde Yumusak Dokuda Yanlis-Pozitif I-131 Tutulumlari. |
Yazici, Bulent; Oral, Aylin; Alcicek, Seyma; Tamsel, Ipek; Akgun, Aysegul |
|
Feb 1, 2019 |
412 |
| A Preliminary Study of Serum Apelin Levels in Patients with Head and Neck Cancer. |
Aktan, Meryem; Ozmen, Hilal Kiziltunc |
|
Feb 1, 2019 |
1787 |
| Trovagene announces US FDA's may proceed notification for Phase 1b/2 trial of Onvansertib in metastatic colorectal cancer patients. |
|
|
Jan 30, 2019 |
212 |
| Trovagene announces US FDA's may proceed notification for Phase 1b/2 trial of Onvansertib in metastatic colorectal cancer patients. |
|
|
Jan 30, 2019 |
208 |
| THE RELATION BETWEEN CA 125, CECT ABDOMEN & PELVIS AND HISTOPATHOLOGICAL FEATURES IN OVARIAN NEOPLASMS. |
Prakash, S.S.; Antony, Charles Jude; Ashwini B.G. |
Report |
Jan 21, 2019 |
3308 |
| A Progressed Case of Stewart--Treves Syndrome in a Patient with Chronic Idiopathic Lymphedema in the Lower Extremity. |
Ozdemir, Mehmet; Sultany, Muhammed Sulaiman; Celikkaleli, Ercan; Ozalp, Burhan |
Clinical report |
Jan 1, 2019 |
1397 |
| Could Nomograms Used to Identify Non-Sentinel Lymph Node Metastases May Be Valuable in Radiotherapy Planning? |
Cihan, Yasemin Benderli |
Report |
Jan 1, 2019 |
1115 |
| Positive effect of single nucleotide RAD51 135G>C polymorphism and low Ku70 protein expression on female rectal cancer patients survival after preoperative radiotherapy. |
Gasinska, Anna; Biesaga, Beata; Widla, Anna Janecka; Darasz, Zbigniew |
Report |
Jan 1, 2019 |
7615 |
| A Rarely Seen Pathology "Intramedullary Spinal Metastasis"; Clinical Series of Five Patients in a Single Institution/Nadir Gorulen Bir Patoloji "Intrameduller Spinal Metastaz"; Tek Bir Saglik Merkezinde Bes Hastalik Klinik Bir Seri. |
Akyuva, Yener; Karadag, Nese; Onal, Cagatay |
Clinical report |
Dec 1, 2018 |
5317 |
| Breast cancer with intraabdominal metastases. Is surgery necessary? |
Panuta, Andrian; Radu, Iulian; Hutanu, Ionut; Musina, Ana-Maria; Buna-Arvinte, Mihaela; Gavrilescu, |
Report |
Dec 1, 2018 |
3076 |
| DIFERANSIYE TIROID KANSERLERINDE RADYOAKTIF IYOT TEDAVISI SONRASI GORUNTULEME: SPECT-BT GORUNTULEMENIN PLANAR GORUNTULEMEYE KATKISI/POST-THERAPY IMAGING AFTER RADIOACTIVE IODINE THERAPY FOR DIFFERENTIATED THYROID CANCER: THE CONTRIBUTION OF SPECT-CT IMAGING TO PLANAR IMAGING. |
SImsek, Duygu Has; Sanli, Yasemin; Kuyumcu, Serkan; Yilmaz, Ebru; Ozkan, Zeynep Gozde; Turkmen, Cune |
|
Dec 1, 2018 |
4782 |
| Portal vein ligation and in situ liver splitting in metastatic liver cancer. |
Aghayeva, Afag; Baca, Bilgi; Atasoy, Deniz; Ferahman, Sina; Uludag, Sezgin; Bilgin, Ismail Ahmet; Be |
Case study |
Dec 1, 2018 |
1772 |
| Atypical Metastasis to the Head and Neck Region: An Analysis of 11 Patients. |
Sahin, Bayram; Doruk, Can; Celik, Mehmet; Ozturk, Erkan; Gunes, Selcuk; Kiyak, Okkes Erkan |
Report |
Dec 1, 2018 |
3948 |
| FDA Grants Priority Review to Genentech's Tecentriq in Combination with Abraxane for the Initial Treatment of People with PD-L1-Positive, Metastatic Triple-Negative Breast Cancer. |
|
|
Nov 20, 2018 |
271 |
| Systemic Therapy in Metastatic Castration-Resistant Prostate Cancer/Metastatik Kastrasyona Direncli Prostat Kanserinde Sistemik Tedavi. |
Dulgar, Ozgecan; Yilmaz, Mesut; Tural, Deniz |
|
Nov 1, 2018 |
2940 |
| Possible Role of Ga-68 PSMA PET/CT in Evaluation of Systemic Treatment Response in Patients with Metastatic Prostate Cancer/Metastatik Prostat Kanserli Hastalarda, Ga-68 Prostat Spesifik Membran Antijen PET/BT'nin Sistemik Tedavi Yaniti Degerlendirilmesinde Olasi Rolu. |
Sivrikoz, Ilknur Ak |
|
Nov 1, 2018 |
4357 |
| Ra-223 Alpha Treatment in Prostate Cancer/Prostat Kanserinde Ra-223 Alfa Tedavi. |
Selcuk, Nalan Alan; Yencilek, Faruk |
|
Nov 1, 2018 |
2165 |
| Lu-177 Prostate Specific Membrane Antigen Therapy of Metastatic Castration Resistant Prostate Cancer/Prostat Kanserinde Lu-177 Prostat Spesifik Membran Antijeni Tedavisi. |
Demirci, Emre; Kabasakal, Levent |
|
Nov 1, 2018 |
3341 |
| Opdivoin Combination with Yervoy Results in Significantly Longer Treatment-Free Survival in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Oct 25, 2018 |
187 |
| Orion and Bayer announce completion of phase III trial of darolutamide; primary end point met. |
|
|
Oct 25, 2018 |
460 |
